CIK 0000749647 · Non-accelerated filer<br>Smaller reporting company
Imunon, Inc.
Sign in to watch- Ticker
- IMNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521256615
- Phone
- (609) 896-9100
- Business address
- 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ, 08648
- Former names
- CELSION CORP, Celsion CORP, CHEUNG LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,942
- in 2 filings
Net −$7,942. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-31 | Eylward Susan General Counsel and Corp Sec | Sale | −2,525 | $1.56 | $4K | 2,896 |
| 2026-08-28 | Tardugno Michael H Executive Chairman of Board | Grant or award | +7,371 | $1.60 | $12K | 89,875 |
| 2026-08-28 | Lindborg Stacy President and CEO | Grant or award | +6,822 | $1.60 | $11K | 100,076 |
| 2026-08-28 | Faller Douglas Vincent Chief Medical Officer | Grant or award | +3,626 | $1.60 | $6K | 37,077 |
| 2026-08-28 | Eylward Susan General Counsel and Corp Sec | Grant or award | +2,525 | $1.60 | $4K | 5,421 |
| 2026-08-17 | Eylward Susan General Counsel and Corp Sec | Sale | −2,449 | $1.63 | $4K | 2,896 |
| 2026-08-14 | Lindborg Stacy President and CEO | Grant or award | +6,615 | $1.65 | $11K | 93,254 |
| 2026-08-14 | Faller Douglas Vincent Chief Medical Officer | Grant or award | +3,516 | $1.65 | $6K | 33,451 |
| 2026-08-14 | Tardugno Michael H Executive Chairman of Board | Grant or award | +7,147 | $1.65 | $12K | 82,504 |
| 2026-08-14 | Eylward Susan General Counsel and Corp Sec | Grant or award | +2,449 | $1.65 | $4K | 5,345 |
| 2026-08-03 | Eylward Susan General Counsel and Corp Sec | Sale | −2,541 | $1.57 | $4K | 2,896 |
| 2026-07-31 | Pellizzari Christine A Director | Grant or award | +6,934 | $1.59 | $11K | 15,076 |
| 2026-07-31 | Dentzer James E Director | Grant or award | +6,934 | $1.59 | $11K | 21,897 |
| 2026-07-31 | Fritz Frederick J. Director | Grant or award | +6,934 | $1.59 | $11K | 21,031 |
| 2026-07-31 | Braun Donald P Director | Grant or award | +6,180 | $1.59 | $10K | 15,499 |
| 2026-07-31 | Eylward Susan General Counsel and Corp Sec | Grant or award | +2,541 | $1.59 | $4K | 5,437 |
| 2026-07-31 | Tardugno Michael H Executive Chairman of Board | Grant or award | +6,358 | $1.59 | $10K | 75,357 |
| 2026-07-31 | Faller Douglas Vincent Chief Medical Officer | Grant or award | +3,649 | $1.59 | $6K | 29,935 |
| 2026-07-31 | Lindborg Stacy President and CEO | Grant or award | +5,010 | $1.59 | $8K | 86,639 |
| 2026-07-20 | Eylward Susan General Counsel and Corp Sec | Sale | −2,150 | $1.78 | $4K | 2,896 |
Page 2 of 6 · 119 trades